text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 38819-10-2 | Product Number: A2739

9-β-D-Arabinofuranosylguanine


Purity: >98.0%(HPLC)
Synonyms:
  • Ara-G
  • Guanine 9-β-D-Arabinofuranoside
Product Documents:
10MG
€16.00
1   ≥40 
50MG
€37.00
1   11  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Supplemental Product Information:

Previously this product had been labeled as a hydrate form both in product name and molecular formula. The hydrate form had no exclusive CAS RN and used to share the same CAS RN as the anhydrous form.
To avoid any misleading information and since moisture in product is considered as an impurity, we have decided to remove the term 'Hydrate' from product name and 'xH2O' from the molecular formula for such products.
Please use it at ease since there is no difference in product quality, even if you see the previous indications on a part of label.

Product Number A2739
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__0H__1__3N__5O__5 = 283.24 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Condition to Avoid Heat Sensitive
CAS RN 38819-10-2
Reaxys Registry Number 1225954
PubChem Substance ID 253662300
MDL Number

MFCD00065486

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Elemental analysis(Nitrogen) 24.00% to 25.50% (calcd.on anh.substance)
Water 4.0 to 7.0 %
Properties (reference)
Melting Point 225 °C
Maximum Absorption Wavelength 252 nm
GHS
Related Laws:
RTECS# MF8301000
Transport Information:
HS Number 2934999090
Application
Ara-G: An Inhibitor of DNA Replication in T-Leukemic Cells

Arabinosylguanine (ara-G) is triphosphorylated by multiple kinases intracellularly to the active nucleotide, ara-GTP, which inhibits the DNA replication in T-leukemic cells. Ara-G is used for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL). From the 2000s, nelarabine (the 6-methoxy pro-drug of ara-G) have been introduced and used for the treatment of T-All and T-LBL. In organic synthesis, ara-G is used as an intermediate for the synthesis of guanosine analogs. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.